DNP:GPWDino Polska SA Analysis
Data as of 2026-03-11 - not real-time
$10.21
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $10.21, comfortably above the 20‑day SMA of 10.43 and the 50‑day SMA of 10.20, signalling a bullish price trend, while the 200‑day SMA sits at 9.99, reinforcing the long‑term up‑trend. Technicals show a neutral RSI of 42 and a bearish MACD histogram, indicating short‑term momentum weakness, but the price remains supported at $10.05 with resistance near $10.65. Valuation metrics are compelling: a trailing P/E of 8.8 is well below the industry average of 16.6 and the P/B of 1.10 sits just above book value, suggesting the market may be undervaluing the fund.
Dividend attractiveness is a key driver, with a 7.57% yield and a payout ratio of 67%, backed by solid operating cash flow of $235.9 M and free cash flow of $64.1 M, indicating sustainability. The fund’s beta of 0.42 and 30‑day volatility of 11.8% point to low market‑risk exposure, though a high debt‑to‑equity of 31.6% warrants caution. Overall, the combination of low multiples, strong cash generation, and high yield positions DNP as a value‑oriented, income‑focused investment with moderate risk.
Dividend attractiveness is a key driver, with a 7.57% yield and a payout ratio of 67%, backed by solid operating cash flow of $235.9 M and free cash flow of $64.1 M, indicating sustainability. The fund’s beta of 0.42 and 30‑day volatility of 11.8% point to low market‑risk exposure, though a high debt‑to‑equity of 31.6% warrants caution. Overall, the combination of low multiples, strong cash generation, and high yield positions DNP as a value‑oriented, income‑focused investment with moderate risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price is near technical support at $10.05
- High dividend yield provides downside cushion
- Bearish MACD suggests limited upside in the near term
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued P/E relative to industry peers
- Sustainable dividend backed by strong cash flow
- Bullish SMA alignment indicating a continuing uptrend
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable utility exposure offers defensive characteristics
- Elevated debt‑to‑equity may limit future flexibility
- Consistent income generation supports long‑term holding
Key Metrics & Analysis
Financial Health
Revenue Growth8.90%
Profit Margin266.32%
P/E Ratio8.8
ROE12.67%
ROA1.78%
Debt/Equity31.58
P/B Ratio1.1
Op. Cash Flow$235.9M
Free Cash Flow$64.1M
Industry P/E16.6
Technical Analysis
TrendBullish
RSI42.2
Support$10.05
Resistance$10.65
MA 20$10.43
MA 50$10.20
MA 200$9.99
MACDBearish
VolumeStable
Fear & Greed Index78.16
Valuation
Fair Value$0.58
GradeUndervalued
TypeValue
Dividend Yield7.57%
Risk Assessment
Beta0.42
Volatility11.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.